Related Experiment Video
Updated: Jan 14, 2026

A Pilot Study on the Repetitive Transcranial Magnetic Stimulation of Aβ and Tau Levels in Rhesus Monkey Cerebrospinal Fluid
Published on: September 3, 2021
Computerized cognitive training enhances cognitive function in Alzheimer's disease by downregulating
Wenbo Zhang1, Jiaqi Song2, Fuxin Zhong1
1Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China.
Computerized cognitive training (CCT) improved cognition in mild Alzheimer's disease (AD) and mild cognitive impairment (MCI). CCT potentially targets the microbiota-gut-brain axis by reducing R. torques and TMAO levels.
Area of Science:
- Neuroscience
- Microbiology
- Gastroenterology
Background:
- The microbiota-gut-brain (MGB) axis is increasingly recognized for its role in Alzheimer's disease (AD) pathogenesis.
- However, effective interventional strategies targeting the MGB axis for AD remain limited.
Purpose of the Study:
- To investigate the efficacy of computerized cognitive training (CCT) in individuals with mild cognitive impairment (MCI) or mild AD.
- To explore the impact of CCT on cognitive function, functional connectivity, and the MGB axis, including gut microbiota and plasma trimethylamine N-oxide (TMAO) levels.
Main Methods:
- A 24-week, single-blind, randomized controlled trial involving 84 participants with MCI or mild AD.
- Participants received either CCT or treatment as usual (TAU).
- Outcomes included cognitive assessment (ADAS-cog), functional connectivity (fNIRS), plasma TMAO, and gut microbiota analysis.
Main Results:
- CCT significantly improved cognitive function (ADAS-cog scores) compared to TAU.
- CCT led to changes in prefrontal functional connectivity and reduced plasma TMAO levels.
- CCT mitigated the expansion of Ruminococcus torques (R. torques), a gut bacterium correlated with cognitive and biomarker changes.
Conclusions:
- A 24-week CCT program enhances cognitive function in MCI and mild AD.
- The findings suggest CCT may act via the MGB axis, specifically by downregulating the R. torques-TMAO pathway.
- This pathway presents a potential therapeutic target for multi-domain interventions in AD.
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive Development During Adulthood

